Rikoon Group’s GSK GSK Stock Holding History

Rikoon Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$1.03M	Hold	22,723	–	–	0.27%	84
2020 Q4	$1.06M	Sell	22,723 -680	-3%	-$31.2K	0.3%	77
2020 Q3	$1.12M	Sell	23,403 -1,880	-7%	-$94.2K	0.34%	71
2020 Q2	$1.3M	Sell	25,283 -225	-0.9%	-$11.5K	0.44%	55
2020 Q1	$1.23M	Buy	25,508 +796	+3%	+$42.5K	0.51%	47
2019 Q4	$1.47M	Buy	24,712 +900	+4%	+$50.1K	0.5%	46
2019 Q3	$1.28M	Hold	23,812	–	–	0.48%	52
2019 Q2	$1.21M	Hold	23,812	–	–	0.45%	57
2019 Q1	$1.26M	Hold	23,812	–	–	0.47%	53
2018 Q4	$1.14M	Buy	23,812 +504	+2%	+$24.8K	0.47%	56
2018 Q3	$1.17M	Hold	23,308	–	–	0.41%	62
2018 Q2	$1.19M	Buy	23,308 +135	+0.6%	+$6.8K	0.45%	58
2018 Q1	$1.14M	Buy	23,173 +1,320	+6%	+$61.5K	0.46%	56
2017 Q4	$983K	Buy	21,853 +112	+0.5%	+$5.17K	0.41%	68
2017 Q3	$1.13M	Sell	21,741 -20,212	-48%	-$1.03M	0.49%	58
2017 Q2	$2.29M	Sell	41,953 -400	-0.9%	-$21.3K	1.01%	28
2017 Q1	$2.17M	Sell	42,353 -4,788	-10%	-$243K	0.96%	31
2016 Q4	$2.37M	Buy	47,141 +15,413	+49%	+$761K	1.04%	28
2016 Q3	$1.71M	Buy	+31,728	New	+$1.74M	1.35%	23

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Rikoon Group's GSK Position: Q1 2021 in Review

Rikoon Group held its GSK (GSK) position steady in Q1 2021 at 22,723 shares worth $1.03M. The position accounts for 0.27% of the portfolio, ranked #84.

Rikoon Group first reported a position in GSK in Q3 2016 and has held it in 19 quarters since. The position peaked at $2.37M in Q4 2016. 775 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

Rikoon Group held 22,723 shares of GSK worth $1.03M as of Q1 2021.
Rikoon Group left its GSK share count unchanged in Q1 2021.
GSK made up 0.27% of Rikoon Group's portfolio in Q1 2021, its #84 holding.
Rikoon Group first reported a position in GSK in Q3 2016 and has held it in 19 quarters since.
Rikoon Group's GSK position peaked at $2.37M in Q4 2016.
775 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.